About Novamed
Novamed is a Healthcare company based in Jerusalem (Israel) founded in 1995, and was acquired by Simplivia in January 2021. Proprietary immunochromatographic diagnostic systems are developed for infection detection. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Novamed offers products and services including Diagnostic Products for Professional Use, Diagnostic Products for Home Use, Prepared Culture Media, Culture Devices, and Research Products. Its focus areas include Medical Devices and Diagnostic Equipment. Its legal entity is Novamed Ltd.
Company details
Novamed Ltd. is involved in the development, manufacturing, and marketing of diagnostic products focused on infectious diseases. The company operates within the healthcare sector, offering a range of innovative solutions for both professional and home use. Products such as prepared culture media, culture devices, and research tools are provided to support laboratory and diagnostic needs. Unique inventions with no global counterparts are included in their portfolio, addressing critical needs in disease detection and management.
- Headquarters Jerusalem, Israel
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website novamed.co.il
- Social LinkedIn
- Acquired by Simplivia (Jan 2021)
- Legal Name Novamed Ltd.
- InvestorsThe Riverside Company
& 1 more
- Acquired by
Products & Services of Novamed
Novamed offers a comprehensive portfolio of products and services, including Diagnostic Products for Professional Use, Diagnostic Products for Home Use, Prepared Culture Media, Culture Devices, and Research Products.
Products are designed for professional infectious disease diagnosis.
Products are made for home-based infectious disease testing.
Media are prepared for laboratory infectious disease research.
Devices are used for culturing in disease diagnostics.
Products are developed for infectious disease research purposes.
Investors in Novamed
Novamed has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include The Riverside Company and Simplivia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt are provided to middle market companies. | riversidecompany.com | Cleveland, United States | ||
Manufactures closed system transfer devices to protect healthcare workers from drug exposure. | 2019 | simplivia.com | Qiryat Shemona, Israel |
Investor details for Novamed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of Novamed
The website of Novamed (novamed.co.il) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 25.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novamed
Complete news archive for Novamed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novamed
Novamed was founded in 1995.
Novamed is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Novamed Ltd. is involved in the development, manufacturing, and marketing of diagnostic products focused on infectious diseases. The company operates within the healthcare sector, offering a range of innovative solutions for both professional and home use. Products such as prepared culture media, culture devices, and research tools are provided to support laboratory and diagnostic needs. Unique inventions with no global counterparts are included in their portfolio, addressing critical needs in disease detection and management.
Novamed offers Diagnostic Products for Professional Use, Diagnostic Products for Home Use, Prepared Culture Media, Culture Devices, and Research Products.
Novamed has 2 investors. Key investors include The Riverside Company, and Simplivia.
Novamed operates through Novamed Ltd..
Yes. Novamed was acquired by Simplivia in January 2021.